See more : CYBERGUN BSA 2 (CYBBT.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Advanced Enzyme Technologies Limited (ADVENZYMES.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Advanced Enzyme Technologies Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Yes Bank Limited (YESBANK.BO) Income Statement Analysis – Financial Results
- Teva Pharmaceutical Industries Limited (TEVA) Income Statement Analysis – Financial Results
- Telecanor Global Limited (TELECANOR.BO) Income Statement Analysis – Financial Results
- SKS Technologies Group Limited (SKS.AX) Income Statement Analysis – Financial Results
- Precision Camshafts Limited (PRECAM.BO) Income Statement Analysis – Financial Results
Advanced Enzyme Technologies Limited (ADVENZYMES.BO)
About Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited researches and develops, manufactures, and markets enzymes and probiotics in India, the United States, Asia, Europe, and internationally. The company offers enzymes for human healthcare and animal nutrition, fruit and vegetable processing, baking, brewing, and malting, and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications. It provides non-food processing enzymes for textile processing, leather, pulp and paper, detergents and cleaning aids, bio-fuels, and biocatalysis. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.23B | 5.41B | 5.29B | 5.00B | 4.42B | 4.18B | 3.88B | 3.30B | 2.93B | 2.22B | 2.15B | 2.19B | 1.71B | 1.16B |
| Cost of Revenue | 3.78B | 1.32B | 1.19B | 1.06B | 871.87M | 814.05M | 890.58M | 756.60M | 682.73M | 554.23M | 557.13M | 609.13M | 550.45M | 531.54M |
| Gross Profit | 2.46B | 4.09B | 4.09B | 3.95B | 3.54B | 3.36B | 2.99B | 2.54B | 2.24B | 1.67B | 1.59B | 1.59B | 1.16B | 629.60M |
| Gross Profit Ratio | 39.43% | 75.62% | 77.42% | 78.90% | 80.25% | 80.51% | 77.04% | 77.08% | 76.67% | 75.05% | 74.03% | 72.24% | 67.86% | 54.22% |
| Research & Development | 255.21M | 8.09M | 6.47M | 6.29M | 4.67M | 4.03M | 4.70M | 1.63M | 83.34M | 91.31M | 10.00K | 71.21K | 0.00 | 0.00 |
| General & Administrative | 240.71M | 218.26M | 207.19M | 158.28M | 120.55M | 133.38M | 136.75M | 92.26M | 74.45M | 96.15M | 105.77M | 80.61M | 59.11M | 60.16M |
| Selling & Marketing | 156.51M | 160.82M | 147.66M | 85.50M | 99.25M | 89.86M | 80.71M | 74.93M | 64.88M | 52.17M | 57.96M | 45.53M | 42.51M | 43.37M |
| SG&A | 397.22M | 379.08M | 354.85M | 243.78M | 219.80M | 223.24M | 217.46M | 167.19M | 139.33M | 148.32M | 163.73M | 126.14M | 101.63M | 103.53M |
| Other Expenses | 0.00 | 254.57M | 45.69M | 29.77M | 41.28M | 46.43M | 7.90M | 19.23M | 4.12M | 17.52M | 970.00K | 11.20M | 15.87M | 1.91M |
| Operating Expenses | 2.89B | 2.87B | 2.41B | 1.85B | 1.75B | 1.72B | 1.51B | 1.14B | 932.90M | 842.60M | 882.90M | 741.80M | 580.16M | 441.74M |
| Cost & Expenses | 4.51B | 4.19B | 3.60B | 2.91B | 2.62B | 2.53B | 2.40B | 1.90B | 1.62B | 1.40B | 1.44B | 1.35B | 1.13B | 973.28M |
| Interest Income | 133.26M | 11.20M | 4.04M | 5.85M | 3.60M | 3.46M | 1.94M | 3.45M | 4.63M | 4.43M | 5.92M | 19.38M | 8.55M | 5.80M |
| Interest Expense | 41.21M | 24.21M | 17.96M | 15.94M | 25.82M | 38.60M | 47.18M | 39.00M | 66.69M | 79.60M | 89.31M | 90.41M | 117.08M | 21.49M |
| Depreciation & Amortization | 352.42M | 350.29M | 349.83M | 287.22M | 257.78M | 211.16M | 182.98M | 127.61M | 87.19M | 90.17M | 99.82M | 74.30M | 54.98M | 49.85M |
| EBITDA | 2.27B | 1.79B | 2.09B | 2.41B | 2.09B | 1.88B | 1.62B | 1.54B | 1.35B | 930.81M | 516.27M | 937.94M | 651.31M | 262.23M |
| EBITDA Ratio | 36.44% | 33.65% | 39.25% | 48.07% | 47.29% | 45.48% | 42.22% | 46.65% | 47.34% | 41.46% | 35.68% | 42.75% | 38.30% | 21.79% |
| Operating Income | 1.73B | 1.26B | 1.66B | 2.04B | 1.77B | 1.64B | 1.48B | 1.40B | 1.31B | 824.34M | 705.25M | 843.52M | 582.01M | 187.85M |
| Operating Income Ratio | 27.72% | 23.25% | 31.48% | 40.69% | 40.07% | 39.17% | 38.10% | 42.40% | 44.79% | 37.11% | 32.87% | 38.44% | 33.98% | 16.18% |
| Total Other Income/Expenses | 149.93M | 147.07M | 45.73M | 64.99M | -300.00K | -28.02M | -76.71M | -36.79M | -126.79M | -75.54M | -420.73M | -70.25M | -106.97M | 3.04M |
| Income Before Tax | 1.88B | 1.40B | 1.71B | 2.10B | 1.79B | 1.62B | 1.39B | 1.37B | 1.18B | 748.09M | 284.52M | 773.23M | 475.77M | 190.90M |
| Income Before Tax Ratio | 30.12% | 25.97% | 32.34% | 42.04% | 40.57% | 38.77% | 35.82% | 41.38% | 40.38% | 33.68% | 13.26% | 35.24% | 27.78% | 16.44% |
| Income Tax Expense | 508.70M | 365.22M | 472.59M | 589.07M | 461.08M | 460.61M | 454.11M | 442.21M | 414.34M | 229.96M | 74.47M | 264.47M | 134.92M | 22.24M |
| Net Income | 1.33B | 1.06B | 1.20B | 1.46B | 1.29B | 1.11B | 900.55M | 906.49M | 758.49M | 509.80M | 197.37M | 498.19M | 337.55M | 166.72M |
| Net Income Ratio | 21.38% | 19.54% | 22.61% | 29.16% | 29.28% | 26.59% | 23.22% | 27.46% | 25.92% | 22.95% | 9.20% | 22.70% | 19.71% | 14.36% |
| EPS | 11.92 | 9.45 | 10.70 | 13.07 | 11.58 | 9.95 | 8.07 | 8.27 | 6.97 | 4.68 | 1.81 | 4.67 | 3.26 | 1.61 |
| EPS Diluted | 11.92 | 9.45 | 10.69 | 13.04 | 11.56 | 9.94 | 8.06 | 8.27 | 6.97 | 4.68 | 1.81 | 4.67 | 3.26 | 1.61 |
| Weighted Avg Shares Out | 111.83M | 111.82M | 111.78M | 111.70M | 111.67M | 111.65M | 111.63M | 110.69M | 108.83M | 108.85M | 108.85M | 106.55M | 103.66M | 103.66M |
| Weighted Avg Shares Out (Dil) | 111.88M | 111.82M | 111.87M | 111.87M | 111.81M | 111.73M | 111.67M | 110.73M | 108.83M | 108.85M | 108.85M | 106.55M | 103.66M | 103.66M |
Source: https://incomestatements.info
Category: Stock Reports